Agreement - March 14, 2016
New co-marketing deal for AMRA
AMRA has entered into a new co-marketing agreement with GE Healthcare. AMRATM Profiler protocol will be made available on future GE Healthcare MRI scanners. AMRATM Profiler is a cloud-based body composition measurement service, which uses images from a rapid, 6-minute MRI scan to deliver fat and muscle measurements. It introduces new standards in body composition measurement […]
Agreement - February 29, 2016
AstraZeneca in licensing agreement with China Medical System Holdings
AstraZeneca has entered into a licensing agreement with China Medical System Holdings Ltd (CMS) for the commercialisation rights in China to its calcium channel blocker, Plendil (felodipine). Plendil was first approved in China in 1995 for the treatment of hypertension or high blood pressure and in 2015 achieved Product Sales of $189 million. Under the terms […]
Agreement - January 28, 2016
Enzymatica and Zymetech sign agreement
Swedish Enzymatica has signed an agreement to acquire Icelandic company Zymetech via a non-cash issue. This acquisition gives Enzymatica international exclusive rights to a patent-protected enzyme, a key ingredient in ColdZyme Mouth Spray, as well as control over production of the enzyme, access to international research and development expertise and Zymetech’s portfolio. The capital contributed […]
Agreement - January 27, 2016
Curida signs agreement with Serviceproduksjon
Norwegian CDMO Curida has signed a framework-agreement with Serviceproduksjon, a subsidary to the Norwegian Pharmace Association. The agreement entails validation of a chemical analytical method for use in analysis of tablets and routine analysis of the particular drug. “Serviceproduksjon received offers from three other contract laboratories and chose Curida based on competency, competitive pricing and […]
Agreement - January 25, 2016
BC Platforms signs partnership with Auria Biobank
BC Platforms has signed a partnership with Auria Biobank to implement and develop a genomic data management system. BC Platforms’ system enables biobanks to efficiently integrate their sample management process with real time clinical information and genomic data. For nearly a hundred years, public health care in Finland has collected millions of human tissue samples […]
Agreement - January 16, 2016
Boule Diagnostics in new agreement
Boule Diagnostics AB has signed a distribution agreement with the American company Medica Corporation Inc., to promote and sell their EasyRA product in the United States. EasyRA is a system for clinical chemistry used to assist in patient diagnosis and determine problems, related to for example liver, kidney function and high cholesterol levels. The product […]
